Skip to main content


Figure 7 | Behavioral and Brain Functions

Figure 7

From: The gamma-aminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens

Figure 7

Effects of acute treatment of baclofen on morphine challenge-induced release of dopamine in the NAc in rat. Drug treatments are as described previously. After 4-day repeated morphine administration, implantation of the microdialysis probes was performed on day 5. On day 8, after basal levels of DA and became stable (a), all rats were subjected to an acute challenge of morphine (3 mg/kg, s.c.) . The dialysates were monitored for 3 h. DA release was expressed as average increase of% basal level over 3 h (b) and percentages of basal mean levels per 20-min intervals (c). ## P < 0.01, compared to saline/morphine control group; * P < 0.05 compared to the morphine/saline treatment group; n = 8 per group.

Back to article page